TY - JOUR
T1 - Effect of granulocyte colony-stimulating factor on bone metabolism during peripheral blood stem cell mobilization
AU - Watanabe, Tsutomu
AU - Suzuya, Hiroko
AU - Onishi, Toshihiro
AU - Kanai, Sachiyo
AU - Kaneko, Michiya
AU - Watanabe, Hiroyoshi
AU - Nakagawa, Ryuji
AU - Kawano, Yoshifumi
AU - Takaue, Yoichi
AU - Kuroda, Yasuhiro
AU - Talmadge, James E.
PY - 2003/1
Y1 - 2003/1
N2 - Granulocyte colony-stimulating factor (G-CSF) has been shown to affect the biochemical markers of bone metabolism, including serum bone alkaline phosphatase (BALP), serum osteocalcin, and urine deoxypyridinoline. To determine the association between bone resorption and formation and the G-CSF-induced mobilization of peripheral blood stem cells (PBSC), we examined these markers during mobilization in 19 healthy donors. The average (± SEM) serum BALP level before treatment was 81.6 ± 17.0 IU/dL, and the level increased significantly to 117.7 ± 15.8 IU/dL on day 5 of G-CSF administration (P < .0001). The urine deoxypyridinoline level before treatment was 12.3 ± 2.4 nmol/mmol creatinine, and this level also increased significantly to 19.4 ± 3.0 nmol/mmol creatinine on day 5 of G-CSF administration (P < .0001). In contrast, the average level of serum osteocalcin significantly decreased from 8.07 ± 2.88 ng/mL to 1.53 ± 0.18 ng/mL on day 5 (P = .0353). During G-CSF administration, we also studied the serum levels of various cytokines (IL-1β, osteoclastogenesis inhibitory factor [OCIF], IL-6, tumor necrosis factor α, transforming growth factor β, interferon-γ, macrophage colony-stimulating factor) related to bone metabolism. Only the kinetics of OCIF were significantly affected. The serum level of OCIF increased immediately after the start of G-CSF administration and remained high during G-CSF administration. These results demonstrate that high-dose G-CSF affects bone metabolism and that OCIF may play a role in bone metabolism. Consistent with the notion that G-CSF affects bone metabolism, a significant correlation was observed between CD34+ cell yield and the increase in urine deoxypyridinoline but not for the changes in serum BALP and osteocalcin levels. This result suggests that bone resorption is either directly or indirectly related to the mobilization of PBSC by G-CSF.
AB - Granulocyte colony-stimulating factor (G-CSF) has been shown to affect the biochemical markers of bone metabolism, including serum bone alkaline phosphatase (BALP), serum osteocalcin, and urine deoxypyridinoline. To determine the association between bone resorption and formation and the G-CSF-induced mobilization of peripheral blood stem cells (PBSC), we examined these markers during mobilization in 19 healthy donors. The average (± SEM) serum BALP level before treatment was 81.6 ± 17.0 IU/dL, and the level increased significantly to 117.7 ± 15.8 IU/dL on day 5 of G-CSF administration (P < .0001). The urine deoxypyridinoline level before treatment was 12.3 ± 2.4 nmol/mmol creatinine, and this level also increased significantly to 19.4 ± 3.0 nmol/mmol creatinine on day 5 of G-CSF administration (P < .0001). In contrast, the average level of serum osteocalcin significantly decreased from 8.07 ± 2.88 ng/mL to 1.53 ± 0.18 ng/mL on day 5 (P = .0353). During G-CSF administration, we also studied the serum levels of various cytokines (IL-1β, osteoclastogenesis inhibitory factor [OCIF], IL-6, tumor necrosis factor α, transforming growth factor β, interferon-γ, macrophage colony-stimulating factor) related to bone metabolism. Only the kinetics of OCIF were significantly affected. The serum level of OCIF increased immediately after the start of G-CSF administration and remained high during G-CSF administration. These results demonstrate that high-dose G-CSF affects bone metabolism and that OCIF may play a role in bone metabolism. Consistent with the notion that G-CSF affects bone metabolism, a significant correlation was observed between CD34+ cell yield and the increase in urine deoxypyridinoline but not for the changes in serum BALP and osteocalcin levels. This result suggests that bone resorption is either directly or indirectly related to the mobilization of PBSC by G-CSF.
KW - Bone metabolism
KW - G-CSF
KW - Mobilization
KW - Peripheral blood stem cells
UR - http://www.scopus.com/inward/record.url?scp=0038651197&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0038651197&partnerID=8YFLogxK
U2 - 10.1007/BF02982606
DO - 10.1007/BF02982606
M3 - Article
C2 - 12568303
AN - SCOPUS:0038651197
SN - 0925-5710
VL - 77
SP - 75
EP - 81
JO - International Journal of Hematology
JF - International Journal of Hematology
IS - 1
ER -